Cargando…

A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer

Profound and durable responses to a single dose of pembrolizumab in lung cancer are rare. We encountered a non‐small cell lung cancer patient showing a deep and durable response with a single dose of pembrolizumab. A 79‐year‐old man reported bloody sputum for several weeks and visited a general phys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondo, Yoshihiro, Kunishige, Michihiro, Kadota, Naoki, Okano, Yoshio, Machida, Hisanori, Hatakeyama, Nobuo, Naruse, Keishi, Shinohara, Tsutomu, Takeuchi, Eiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841699/ https://www.ncbi.nlm.nih.gov/pubmed/35023292 http://dx.doi.org/10.1111/1759-7714.14314

Ejemplares similares

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021)

Late‐onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer
por: Ichihara, Seiya, et al.
Publicado: (2022)

Non‐small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib
por: Kunishige, Michihiro, et al.
Publicado: (2022)

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient
por: Okano, Yoshio, et al.
Publicado: (2021)

Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
por: Takeuchi, Eiji, et al.
Publicado: (2022)

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors
por: Takeuchi, Eiji, et al.
Publicado: (2023)

Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
por: Takeuchi, Eiji, et al.
Publicado: (2021)

Solitary costal plasmacytoma mimicking lung cancer metastasis
por: Kadota, Naoki, et al.
Publicado: (2017)

Massive eosinophilia despite severe aplastic anemia
por: Takahashi, Aya, et al.
Publicado: (2022)

Elevated Levels of Intelectin-1, a Pathogen-binding Lectin, in the BAL Fluid of Patients with Chronic Eosinophilic Pneumonia and Hypersensitivity Pneumonitis
por: Shinohara, Tsutomu, et al.
Publicado: (2018)

Diffuse (18)F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma
por: Harada, Shu, et al.
Publicado: (2016)

Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer
por: Okano, Yoshio, et al.
Publicado: (2021)

Kikuchi-Fujimoto disease associated with community acquired pneumonia showing intrathoratic lymphadenopathy without cervical lesions
por: Naito, Nobuhito, et al.
Publicado: (2015)

Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma
por: Tokuyasu, Hirokazu, et al.
Publicado: (2019)

Improvement in idiopathic nonspecific interstitial pneumonia after smoking cessation
por: Shinohara, Tsutomu, et al.
Publicado: (2014)

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations
por: Kunishige, Michihiro, et al.
Publicado: (2023)

BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6
por: Tobiume, Makoto, et al.
Publicado: (2014)

Asymptomatic tracheal MALT lymphoma discovered on spirometric findings presenting with elevated respiratory resistance
por: Kadota, Naoki, et al.
Publicado: (2015)

Type A thymoma: a rare cause of neoplastic cardiac tamponade with long-term survival
por: Takashima, Mika, et al.
Publicado: (2022)

Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report
por: Okano, Yoshio, et al.
Publicado: (2016)

Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma
por: Shinohara, Tsutomu, et al.
Publicado: (2013)

Cavitary lung cancer with cartilage tissues in the wall mimicking aspergilloma
por: Taoka, Takashige, et al.
Publicado: (2017)

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
por: Cyriac, Sanju, et al.
Publicado: (2021)

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)

Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report
por: Kamei, Maiko, et al.
Publicado: (2015)

Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report
por: Lepir, Tanja, et al.
Publicado: (2019)

Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
por: Chan, John K., et al.
Publicado: (2020)

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021)

Pembrolizumab-Induced Vitiligo in Esophageal Squamous Cell Carcinoma Patient With Durable Complete Response
por: Wilkins, Matthew C, et al.
Publicado: (2021)

Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report
por: Takeuchi, Eiji, et al.
Publicado: (2020)

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab
por: George, Saby, et al.
Publicado: (2018)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
por: Poma, Anello Marcello, et al.
Publicado: (2021)

A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
por: Porragas-Paseiro, Hector S., et al.
Publicado: (2023)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020)

Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report
por: Nguyen, Olav Toai Duc, et al.
Publicado: (2020)

Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
por: Khetan, Varun, et al.
Publicado: (2021)

Cardiopulmonary arrest due to bronchoscopy-induced Takotsubo syndrome in a patient with antineutrophil cytoplasmic autoantibody-associated lung disease: a case report
por: Okano, Yoshio, et al.
Publicado: (2022)

Bronchopleural fistula following M. abscessus infection 11 years after lobectomy for lung cancer
por: Inayama, Mami, et al.
Publicado: (2013)

Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study
por: Alvarado, Diego, et al.
Publicado: (2022)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Zeng, Tian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6g5tb27ss0h80ncavbo4in5o96